---
category: listing
circular_id: a11efbc042efeed3
date: '2025-11-27'
description: Shareholding pattern filed under Regulation 31(1)(a) of SEBI (LODR) Regulations,
  2015 for SUDEEP PHARMA LIMITED post-issue as on 27.11.2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={DBB845B2-D051-440D-A615-288F2EE0DDB4}&noticeno=20251127-58&dt=11/27/2025&icount=58&totcount=66&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine shareholding pattern disclosure post-listing for a newly listed
  company with no significant encumbrances or outstanding securities
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251127-58&attachedId=3674a91a-7486-4179-89f3-0e6cd1f66dc0
processing:
  attempts: 1
  content_hash: 547c7ccc086a48da
  processed_at: '2025-11-27T18:39:07.679895'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-11-27T13:21:48+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={DBB845B2-D051-440D-A615-288F2EE0DDB4}&noticeno=20251127-58&dt=11/27/2025&icount=58&totcount=66&flag=0
severity: low
source: bse
stocks:
- SUDEEPPHARMA
tags:
- listing
- shareholding-pattern
- equity-shares
- regulation-31
- post-issue
title: Listing of Equity Shares of SUDEEP PHARMA LIMITED
---

## Summary

SUDEEP PHARMA LIMITED has filed its shareholding pattern under Regulation 31(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing is for equity shares post-issue as on November 27, 2025.

## Key Points

- Shareholding pattern filed for equity shares as on 27.11.2025 (post-issue)
- No partly paid-up shares issued by the company
- No convertible securities, warrants, or ESOPs outstanding
- No depository receipts issued against shares
- No shares held by promoters are pledged or under Non-Disposal Undertaking
- No shares held by promoters are otherwise encumbered
- Company does not have equity shares with differential voting rights
- No shares in locked-in status
- No significant beneficial owner

## Regulatory Changes

No regulatory changes introduced. This is a standard disclosure filing as required under existing SEBI (LODR) Regulations, 2015.

## Compliance Requirements

- Listed entities are required to submit shareholding pattern under Regulation 31(1)(a) of SEBI (LODR) Regulations, 2015
- Declaration must be provided regarding the status of partly paid shares, convertible securities, warrants, ESOPs, depository receipts, locked-in shares, pledged shares, and encumbrances
- Where 'NO' is declared, values are considered as 'Zero' by default

## Important Dates

- Filing Date: November 27, 2025
- Shareholding Pattern As On: November 27, 2025 (Post-Issue)

## Impact Assessment

This is a routine post-listing disclosure with minimal market impact. The shareholding pattern indicates a clean capital structure with no encumbrances, outstanding convertible instruments, or complex securities, which is typical for newly listed companies. The disclosure provides transparency to investors regarding the ownership structure and capital composition of SUDEEP PHARMA LIMITED.